Disease management (DM) is a compelling concept. For many chronic conditions, DM programs can simultaneously improve clinical outcomes and patient satisfaction while reducing the net cost of medical care. However, many programs are ultimately abandoned or fail to achieve their full potential due to difficulties encountered in implementing what seems like a sound program design. Implementation issues and barriers can be grouped into three major categories: (1) lack of strong physician leadership; (2) failure to align incentives; and (3) failure to identify and address operational issues. Organizations that wish to implement DM programs should develop a comprehensive plan that fosters physician leadership, rewards all stakeholders, and proactively identifies and resolves operational issues. By addressing these critical areas, organizations will greatly increase the likelihood that their programs will succeed and be implemented in a reasonable period of time.
INTRODUCTION D
ISEASE MANAGEMENT (DM) is not a new concept. Over 20 years ago, before the term "disease management" existed, staff model health maintenance organizations (HMOs) like Harvard Community Health Plan, Kaiser Permanente, and Group Health Cooperative of Puget Sound created programs to "manage" patients with chronic illnesses such as diabetes, hypercholesterolnemia, depression, and acquired immunodeficiency syndrome (AIDS). Until recently, DM was largely confined to these highly sophisticated healthcare organizations. These HMOs were able to develop and implement their programs with relative ease because they possessed a unique set of assets: a strong structure of physician leadership, sophisticated data systems, employed physicians and nurses, financial risk for large populations, and a culture that valued continuous improvement in quality of care. These early models proved that it was possible to improve quality of care and reduce costs for patients with certain chronic illnesses.
More recently, a broad range of healthcare organizations such as individual practice association (IPA) model HMOs, physician hospital organizations (PHOs), and risk-bearing physician organizations have tried to develop and implement DM programs. Once again, the drivers for these initiatives are financial risk for a population and a desire to improve quality of care. However, these organizations do not pos-sess many of the other attributes inherent in the staff model HMOs. These less integrated organizations often fail at successfully implementing DM programs that meet a reasonable set of criteria that define success: program implementation within a reasonable period of time (less than one year); high levels of patient enrollment; improvement in process and outcome clinical measures of quality; reduced total patient costs; improved patient functional status; and enhanced patient and provider satisfaction.
In addition to the managed care and provider organizations mentioned above, over 100 DM vendors now exist. They offer a wide range of services ranging from "turnkey" comprehensive programs to tools (such as information systems or home-monitoring devices) that can augment programs built by provider or managed care organizations. Although DM vendors face the same challenges as providers and managed care organizations, their ability to focus on a narrower set of activities, 1 economies of scale, and clinical and technical tools enable them to have a better track record at successfully implementing DM programs. However, this article will take a neutral stance on the "build versus buy" debate and focus on the barriers to successful implementation that face provider, managed care, and vendor organizations.
In our experience, the vast majority of barriers and factors preventing successful implementation of DM programs fall into one of three "buckets": (1) lack of strong physician leadership; (2) failure to align incentives, and (3) failure to identify and address operational issues.
LACK OF STRONG PHYSICIAN LEADERSHIP
Virtually all DM programs rely on three basic strategies to positively impact clinical and financial outcomes for a population of patients with a given disease: (1) improving patient compliance with medications and adoption of healthier lifestyles, (2) improving physician compliance with established guidelines or standards of care, and (3) rigorously monitoring patients so that clinical intervention can occur before hospitalization is required. For example, with respect to patients with congestive heart failure (CHF), 33% of all hospital admissions are a consequence of lack of patient compliance with medications or a low sodium diet, 2 while 32% of admissions are due to failure of physicians to prescribe appropriate drugs and dosages for CHF. Although DM programs can impact patients to some degree without the "buy-in" of physicians, clearly a large opportunity for improvement is missed if physicians are not influenced positively by the DM program.
Most physicians believe that they are already delivering outstanding clinical care, and that DM programs are a time consuming and unnecessary intrusion into their practices. However, many studies have demonstrated that physicians frequently fail to follow widely disseminated clinical standards and guidelines. For example, a large study performed by the Medstat Group showed that only 27% of severe asthmatics receive immunosuppressive agents, 29% of diabetics receive annual retinal eye exams, and 40% of patients with CHF have an echocardiogram performed. 2 Each of these clinical interventions is widely accepted by expert physician panels as representing a basic standard of care, yet many physicians are unaware of the guidelines, choose not to follow them, or fail to implement processes within their practices to assure that patients receive the recommended interventions.
A related physician-driven problem occurs when a patient is taken off of a key medication (or the dose is reduced to a level where it is not effective). This type of event is often triggered by a side effect (e.g., mild dizziness in a patient with CHF on an angiotensin converting enzyme ACE-inhibitor). The problem is often compounded when the physician discontinuing or lowering the dose of the drug is different from the one who originally prescribed the drug. Although these actions may appear reasonable at the time, needed medications are often never restarted or appropriate substitutes are not considered.
On a practical level, directly confronting physicians with the fact that they are not delivering care consistent with consensus-based standards is rarely successful. The response "my patients are sicker or different" is the norm. In addition, physicians are often bom-barded with reams of "practice profiles" from competing managed care organizations, each of which has, only a small portion of the physician's patients enrolled in their DM programs. It is the authors' experience that most physicians ignore these reports and feel they are flawed, contradictory, or intrusive.
In attempting to understand the potential benefit of strong physician leadership, we need to understand why physicians fail to follow established standards of care. There are a large number of studies that attempt to understand why physicians fail to consistently follow guidelines. In a recent summary of this literature, Cabana et al. reviewed 76 studies that explored 293 barriers to physician guideline adherence. 3 The most common barriers identified were lack of awareness, limited familiarity, lack of agreement with the guideline, self-efficacy, and the inertia of previous practice. It is also clear from the literature that simple "passive" interventions such as continuing medical education (CME) courses don't remedy this situation. Conversely, initiatives are more likely to be effective when they are multifaceted and use a "social influence" model of change. [4] [5] [6] A key element of this model is the use of local opinion leaders to significantly impact the adoption of guidelines among their peers. [7] [8] [9] A recent randomized controlled trial used this approach to study the adoption of six recommendations included in guidelines endorsed by the American Academy of Neurology for the evaluation and management of dementia. 10 Four hundred and seventeen neurologists in six urban regions of New York were randomized to an education intervention that included a seminar led by a local opinion leader. A control group of neurologists did not participate in the intervention. The neurologists in the intervention group were significantly more likely to follow three of the six recommendations. The odds ratios for these three interventions of 4.1, 2.8, and 10.8 demonstrate a major difference in the performance of the two groups with respect to adoption of the guidelines.
These two important facts-(1) physicians often don't follow well established standards of care, and (2) the process of getting physicians to adopt these standards is complex and requires a multifaceted approach that incorporates the endorsement of local opinion leaders-create the dynamic that makes it critical that DM programs incorporate strong physician leadership at a local level. Successful DM programs cultivate local physician leadership through a variety of mechanisms. Many create a local physician advisory board that reviews and modifies national guidelines, advises the sponsoring organization (usually a managed care organization) on whether to "build or buy" a DM program, and suggests how implementation problems can be overcome. Invariably, the members of the physician advisory board become "champions" for a fledgling DM program. 11 Another approach to fostering local leadership is to have one or more local opinion leaders serve as medical director(s) for the DM program. In this role they provide clinical oversight to the nurses and allied health professionals who provide care management services (e.g., telecare nurses or respiratory therapists who manage patients with asthma), conduct quality assurance (QA) reviews on adverse events or outcomes, review outcomes data, chair the physician advisory committee, and provide feedback to physicians who consistently fail to follow well-established standards of care endorsed by the committee. Once again, medical directors, through their intense involvement with the program, become strong leaders advocating for the DM initiative.
Many physicians have significant reservations about supporting DM initiatives. Some view DM programs as a time-consuming intrusion into their practices. In some cases this is true, as the DM programs of multiple managed care organizations can overwhelm physicians with letters, guidelines, faxes, and phone calls. In the relatively short time span of a typical office visit, few physicians have the time to review all compliance issues, educate patients about lifestyle and risk reduction issues, and compare their practice patterns to the newest guidelines. Physician leaders can educate their colleagues that DM initiatives assist them in these vital components of caring for patients with chronic illnesses. Furthermore, they must reassure their colleagues that they maintain control of patient care and that any additional time required to review care plans or interact with case managers will result in higher quality of care.
Many physicians, especially specialists, are concerned that DM programs will reduce patient visits or referrals. In reality, most DM initiatives do not impact visits or referrals, but instead provide additional services such as patient education, monitoring of patients between office visits, a 24-hour nurse line, and so forth. Here again, physician leaders can share relevant data and program design information with their colleagues and address their concerns. In summary, physicians do not rapidly adopt clinical protocols that are at the core of most DM programs and they have reasonable concerns about how these programs will impact their practices. Physician leaders can help overcome these barriers. Therefore, having a cadre of effective physician-champions is a necessary element to successfully implementing a DM program.
FAILURE TO ALIGN INCENTIVES
Several years ago, one of the authors spent an enlightening hour with a well-trained cardiologist who was the senior partner of a prosperous cardiology practice. In this discussion, the author shared the exciting emerging data that the hospital admission rate for patients with Class III or IV CHF could be reduced up to 60% by having trained nurses educate and monitor patients via telephone and in patients' homes between visits with their physician. The cardiologist was impressed with the data and hypothesized that most of the improvement was due to the fact that, despite his best efforts to educate patients regarding dietary and medication compliance, many patients had lapses in their sodium restriction, self-monitoring of weight, or missed doses of their medication. He believed that the nurses in the DM program modified patient behavior in the "gaps" between office visits or hospitalizations.
When asked why he didn't hire and train a nurse in his office to perform these services, his response was clear and logical-"I would love to, but I won't be reimbursed for providing these services. In fact, a program like this will cost my practice money!" Furthermore, he expressed concern that hospital administrators might have a negative view of the program as it would decrease admissions to their facility. The irony of this situation is that although it costs $2000 to $3000 per year to provide a comprehensive DM program to a patient with severe heart failure (this includes patient identification, data collection, care management interventions, education of physicians, and outcomes reporting and the associated overhead of an information system), the reduction in hospitalizations and associated home care services saves $10,000 to $16,000 per year per patient. The point of this vignette is that DM programs can simultaneously improve quality and produce savings net of the cost of the program; however, the incentives for physicians, doctors, and managed care organizations are usually not aligned.
So how can incentives be aligned to foster an environment that will enable good DM programs to be rapidly implemented? One simple strategy is to pay a fee-for-service "case management" fee to the "managing physician" (i.e., the primary care or specialist physician responsible for managing the disease in question). The case management fee is not a referral fee, but instead, it is compensation for the time the physician takes reviewing a care plan developed by the DM care manager, taking calls from care managers if a patient requires acute intervention, and reviewing outcomes data. It is best structured as an annual fee paid directly to the physician after the patient is in a DM program for a requisite number of months.
There are alternative methodologies for aligning physician incentives. Organizations can establish a "quality bonus" that is paid out to physicians who support and actively participate in DM initiatives. An innovative methodology is to create a gain-sharing pool where the physicians actually share some of the financial savings with the organization that bears financial risk-usually a managed care organization or risk-bearing delivery system. Regardless of the methodology, incentive models that reward physicians for supporting DM programs should be simple, well publicized, and intuitive, or they will have limited impact.
FAILURE TO IDENTIFY AND ADDRESS OPERATIONAL ISSUES
Organizations hoping to successfully implement a DM program must not only provide strong physician leadership and aligned incentives, but also identify and effectively address a set of critical operational issues. Many clinicians have the naïve view that all it takes to create a DM program is a sound set of clinical guidelines and a few committed physician leaders. While these elements are necessary, they are not sufficient unless the operational details of a program are thoughtfully designed prior to implementation. In addition, unforeseen operational issues always arise as a new program is being put in place, and these issues must be addressed promptly so that momentum and enthusiasm is not lost. The following are the most common operational issues and barriers that implementers of DM programs need to address.
Selecting a disease
Determining the need for a particular DM program begins with an analysis of available data, including inpatient and outpatient claims, pharmacy, and lab data. There may also be clinical data available from chart reviews done within the organization for various purposes. The decision may also be influenced by organizational decisions around quality improvement projects, Health Employer Data Information Set (HEDIS) Measurements, National Committee for Quality Assurance (NCQA), and Health Care Financing Administration (HCFA) requirements.
A careful examination of the analyses described above will help identify opportunities for improvements and savings in a given disease or group of diseases. The availability of accepted clinical guidelines for a specific condition may also help determine which diseases can be implemented easily and offer the best return on investment. Once a "target disease" is selected, a thoughtful project plan for proceeding is critical to the successful implementation of the program.
Population identification
The analyses described above will help identify the population of patients that stand to benefit most from the DM program. In addition, review of the clinical literature will provide valuable information about the level of intervention required for various segments of the affected population. One example is the wellknown Framingham data that predicts how multiple combinations of risk factors affect the probability of a patient having a cardiac event within specific time frames. Using this information it is possible to determine which patients are at highest risk for a cardiac event and therefore target these patients for the most robust care management services.
Further decisions regarding the approach for the program are required to move forward with program design and implementation. What are the eligibility criteria for entry into the program? Does it make sense to exclude patients with certain diagnoses (e.g., malignant neoplasms or AIDS)? If a patient has multiple chronic diseases and is eligible for multiple programs, should he or she be enrolled in each program, and if so, should he or she have multiple care managers? Which program gets "credit" for any financial savings? Answers to such questions may seem trivial, but they provide an important framework upon which all involved stakeholders can understand the program.
Clearly defined outcomes
The expected outcomes, both clinical and financial, are drivers of the optimal design of a DM program. Without clarity around the outcomes, it is impossible to put together a sound program. Early in the program development and contracting phase, it is important to carefully define all outcomes and seek agreement among all involved parties as to the metrics that will be used to measure improvement. Usually dimensions of outcomes include the following: clinical process measures, clinical outcomes measures, utilization of resources, cost, health status, and patient satisfaction.
The outcomes, each associated metric, the frequency of measurement, and the method of collecting the data should be clearly spelled out in the contract or program charter. Clearly defined outcomes provide the framework that allows all involved parties to begin thinking about the processes, technology, and human resources that will be required to achieve the desired goals. For example, in a coronary artery disease program, a desired outcome might be improved lipid levels. Will the improvement be determined by low density lipoprotein (LDL) levels, high density lipoprotein (HDL) levels, or both? How will a baseline measurement be collected and how frequently during the performance period should the measurement be obtained? Will patient-reported measurements or actual testing be the required method of collection? The answers to these questions will shape the ultimate structure a DM program will take.
Data requirements
Data issues frequently represent considerable challenges to all parties involved in the implementation of DM programs. Early on, it is critical to identify all necessary data requirements and analyze the difficulty of finding the data, obtaining the data, and the reliability of the data. Too little time spent on identifying barriers and issues related to data collection at the beginning of the project may lead to frustration and disappointment as the program is underway-as often there will be difficulties tracking and reporting clinical and financial progress.
Data analysis
To prove that a DM program achieves its clinical and financial goals it is necessary to create a "baseline" that represents the current clinical and financial state of the target population. Agreement among all parties as to how this baseline will be determined and who will actually analyze the data is important. If the program is "built," will the data be analyzed by internal staff and sent to an outside party for validation? If a vendor partner is chosen, will the client and vendor both analyze the data and come to an agreement or will one party be chosen to do the analysis? Completion of the project plan and a contract with a vendor (if the program is outsourced) requires development of an efficient reconciliation process to compare program outcomes to the baseline data.
Reporting format
Examination of the desired program outcomes gives clues as to what needs to be reported to determine program effectiveness. During program design or during the contracting phase, it is a worthwhile exercise to consider the optimal frequency of reporting and how to display reports in a way that is meaningful to both clinicians and administrators. Most organizations require interim reporting to monitor program progress. Clear and intuitive reporting processes are crucial ingredients toward maintaining organizational buy-in during the period between program launch and before a first reconciliation is performed (usually 12 to 18 months after the program is launched). Creative strategies to show program progress before claims data is available might include using utilization management data as a proxy calculation for true savings.
Duplication of services
Leveraging local expertise and resources rather than imposing outside solutions is a strategy that pays off in many ways. In many DM programs, vendors build programs where all components are imported from the corporate office and reassembled at the program site. Specialty nurses for such programs are recruited nationally, trained in the corporate offices, and deployed to the appropriate city. Corporate Medical Directors, usually specialists in their field, provide program oversight for patients across many clients. Patients talk to care management nurses, and sometimes physicians, whose names are unfamiliar and who live in different parts of the country. In this type of structure, all program components are designed and delivered by the DM company.
While this strategy allows the vendor to protect the integrity of the original program design and enjoy economies of scale, the client often interprets this approach as rigid. In addition, patients tend to be wary and untrusting of advice delivered by strangers in another city. Clients who built good contractual relationships with specialty services in their commu-nity find it difficult to advertise new programs that may replace these well-known local services. Finally, community physicians are hesitant to refer to the DM programs, preferring to refer their patients to trusted local services or programs.
The same issues frequently plague health plans or employer groups who choose to build their own programs internally. Internal case managers are trained to deliver chronic DM programs telephonically. While this approach may provide a local "flavor," the internal program frequently displaces community-based programs and disrupts relationships patients have with local disease experts. In addition, physicians often react negatively to programs offered by managed care organizations and doubt the capabilities of programs offered by employer groups.
An alternative approach of delivering some services from a central location, and offering clients the ability to deliver some services with local expertise, can be used to overcome these problems. For the vendor, the health plan, or the employer group developing the DM strategy, the engagement of local expertise benefits all involved parties. Utilization of local experts brings additional clinical resources to the program and assists in the process of finding and building support from local program champions. Local experts have a unique understanding of the environment in which they practice, including practice patterns, specialty referral preferences, and availability and capability of community resources. DM programs built internally or developed with an external vendor partner can incorporate local expertise in a variety of ways. One of the first tasks in any DM implementation is assessment of community resources. Hospitals may have invested considerable time and money into care pathways and follow-up outpatient programs and/or support groups. Local home health agencies frequently develop expertise in a particular disease. Physician groups may have special outpatient clinics that deliver a disease-specific service. A local agency may have designed patient education material that is being used by hospitals or providers in the community.
While it won't be possible to incorporate all local resources into a DM program, it may make sense to subcontract parts of the DM program out to local entities. In addition, it may make good business sense for DM programs to direct patients to free services that are offered by community resources, and in this way validate trusted local services while adding richness to the DM offering. Finally, it may be possible to uncover client-developed services or capabilities that are applicable to the patient population that would build internal customer support and enhance the DM program.
Staffing the DM program with nurses and medical directors hired from the community offers another important opportunity to incorporate local expertise into a DM program. Local professionals, who have experience working within the customer environment, quickly build trust and acceptance of the new program. Building upon existing trust and confidence, local professionals may find it possible to approach physicians and clients in a more assertive fashion, and in this way, produce improvements in clinical outcomes more rapidly.
Well-defined project plan and multidisciplinary team
A comprehensive implementation plan is key to the efficient "roll-out" of a DM product. Whether the program is built internally or outsourced to a vendor, implementation planning with all involved parties ensures completeness. In the early days of the DM industry (i.e., the early 1990s) many purchasers wished to place all responsibility for implementation in the hands of an outside vendor, hoping for a "turnkey" operation. Frequently, this approach prolonged the ramp-up phase and promoted a disjointed approach to patients and physicians. In the same way, managed care organizations who built internal programs frequently ran the programs out of a single department without involving departments such as customer service or provider relations, and in so doing, missed out on the additional resources that could have brought more exposure and support for the program. Including a multidisciplinary team in the implementation planning brings the strengths and expertise of multiple organizations and departments to the project.
In building the project plan with a multidisciplined team, all parties can contribute to the implementation resource pool. The entire team can brainstorm the many categories of tasks to complete. Once the entire list of tasks is outlined, experts from all areas can be assigned to tasks or miniprojects. These smaller teams can work together to solve problems creatively, develop processes, and lessen the need for rework. Weekly meetings of the entire implementation team allow members to understand barriers and appreciate progress that is made. Problem tasks may affect many different smaller teams, and working together to find a solution invariably brings more creative and potent ideas to the table.
Effective patient and physician communication
As the implementation team reviews the many tasks that require completion prior to "Go-Live" day, patient and physician communication often gets bumped to a lower priority as seemingly more important issues surface. It is a mistake to leave the tasks associated with patient and physician communication to the end of the implementation phase. These communication pieces include introductory letters to physicians and patients, patient and provider newsletters, patient educational materials, news releases, and internal communications. Companies offering DM programs to Medicare and Medicaid populations are subject to approval of materials by the governing body prior to program implementation. This approval process generally takes 90-120 days. Organizations may have internal committees that approve the content of mailings to members and providers, a process that may take 30-90 days. Most organizations have guidelines about how these materials are branded. All of these tasks require time, and it can be disappointing to be ready to roll out the program, only to find approval of communication materials holding up the process.
A well-planned approach to communicate with members and providers helps pave the way for initial member and physician engagement in the program. A multifaceted approach, using general newsletters, personal letters, a Web page, and visits to physician offices will pay off when nurses begin contacting patients and providers about the program.
Interface identification
Regardless of the complexity of a DM program and whether the program is built or purchased, the number of interfaces required to support the program can be staggering. An interface may be defined as any place in the program design in which information, communication, or tasks are handed from one entity to another. A "walk-through" of the program, as designed, is a valuable method to identify each interface. Examples of important interfaces include data transfers from one department to another, or from the organization to the vendor; communication between nurses and patients, or nurses and physicians; and transfer of clinical information requiring an action from a nurse to a physician or program manager. Identification of the many interfaces is needed to allow the program to function smoothly and to enable the creation of workflows that depict all critical processes.
The multidisciplined project team can tackle workflow development by assigning specific interfaces and needed workflows to small groups. These assignments should go into the project plan and be tracked for completion. Once the small group has agreed upon the basic workflow and related processes, as well as a quality improvement (QI) plan to measure the accuracy and effectiveness of the workflow, the entire team can review and make recommendations for improvement, and determine where specific workflows need to be integrated with other workflows. One by one, each interface and related workflow should be reviewed, modified, approved, and woven into the master work plan.
Postimplementation support
Program "Go-Live" day is an exciting and rewarding event. This is the culmination of weeks of work, and all contributors to the program design and implementation should feel gratified when the first patient interaction happens. While it is tempting to disband the proj-ect team at this point, there are good reasons to allow the team to continue working together through the first 6 months of the program.
It is important to make sure all workflows and processes perform as expected. The designed QI plan for any given workflow may identify areas for improvement or redesign. Issues identified related to communication workflows will require immediate solutions to keep the program moving forward on schedule. Interfaces requiring transmission of data from one department or outside entity into a database require testing and tweaking as problems are identified. As early as possible, interim outcomes should be gathered and analyzed to identify weaknesses, barriers, or omissions in the program design or effectiveness.
The ability to respond quickly to identified postimplementation issues and make changes quickly is critical to obtaining clinical and financial outcomes within the first performance year. Keeping the original project team intact for 6 months into the program year allows the people who built the processes and understand them best to solve any problems as quickly and efficiently as possible. Therefore, it is helpful to include the key postimplementation tasks into the project plan from the beginning, and set expectations that the project team will stay intact for this critical period of time.
SUMMARY
Disease management is a concept whose time has come. It is one of the few basic medical management strategies that can simultaneously improve patient outcomes while dramatically reducing costs (for some diseases). Nonetheless, the healthcare landscape is littered with the remains of many DM initiatives that were unsuccessful and subsequently abandoned. In our experience, most of these "fatalities" were not due to poor design of the clinical interventions. Instead, they were due to the failure of the sponsoring organizations to address the three key sets of issues integral to successful implementation of a DM program: fostering strong physician leadership, aligning financial incentives, and identifying and addressing operational issues. A proactive approach to achieving each of these objectives maximizes the likelihood that a DM program will be successfully implemented in the desired time frame.
